More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$49.23B
EPS
0.15
P/E ratio
25.5
Price to sales
3.31
Dividend yield
1.057%
Beta
0.19167
Previous close
$11.27
Today's open
$11.06
Day's range
$11.03 - $11.22
52 week range
$8.71 - $11.42
show more
CEO
Brian McNamara
Employees
24000
Headquarters
Weybridge, Surrey
Exchange
New York Stock Exchange
Shares outstanding
4.45B
Issue type
American Depository Receipt
Healthcare
Pharmaceuticals
New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief
WARREN, N.J.--(BUSINESS WIRE)--The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address the root cause of tooth sensitivity. Based on data showing that 85% of people with sensitive teeth want solutions that repair sensitivity by addressing the root cause of their pain, Sensodyne developed Clinical Repair to go beyond temporary relief and actively repair sensitive areas of teeth with co.
Business Wire • Feb 10, 2026

Citi maintains 'sell' on Haleon, cuts target price on FX optimism and US channel concerns
Citi has reiterated its 'sell' rating on Haleon PLC (LSE:HLN, NYSE:HLN) and trimmed its price target from 340p to 335p, warning that the consumer health group's valuation fails to reflect mounting pressures from US retail shifts and slowing brand momentum. The move comes despite a recent rally in the shares, which closed on Wednesday at 377.20p.
Proactive Investors • Jan 22, 2026

Haleon hit by channel shift concerns
Haleon PLC (LSE:HLN, NYSE:HLN) shares dropped slightly after Deutsche Bank reiterated its 'sell' rating on the maker of Sensodyne and Panadol, warning of changes in consumer trends that may show up in next month's results. The bank's analysts trimmed their target price from 340p to 335p, well below the last close of 377.2p, saying the shares fail to reflect mounting risks from changing sales channels and weakening consumer trends.
Proactive Investors • Jan 22, 2026

Are Consumer Discretionary Stocks Lagging Haleon PLC Sponsored ADR (HLN) This Year?
Here is how Haleon PLC Sponsored ADR (HLN) and Reynolds Consumer Products (REYN) have performed compared to their sector so far this year.
Zacks Investment Research • Jan 21, 2026

Haleon poised to deliver solid margin growth despite weaker cold season
Night Nurse maker Haleon PLC (LSE:HLN, NYSE:HLN) is expected to report a strong finish to 2025 next month, with investors watching closely for signs of margin improvement despite a weaker cold and flu season in key markets. Analysts at UBS forecast fourth-quarter organic sales growth of 3.1%, slightly below consensus estimates of 3.7%, after a delayed start to the cough and cold season in Europe and North America.
Proactive Investors • Jan 21, 2026

TUMS Unveils Sweepstakes and Limited-Edition Burn Ball to Help Fans "Pass the TUMS" Ahead of Football's Big Game
Viral mega-creator Airrack joins the brand for a playful campaign featuring trick shots, social sweepstakes and heartburn relief that's passable WARREN, N.J., Jan. 6, 2026 /PRNewswire/ -- One in four Big Game watchers experience occasional heartburn from their favorite foods — and 75% of those fans are unprepared, without relief on hand*.
PRNewsWire • Jan 6, 2026

Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree
WARREN, N.J.--(BUSINESS WIRE)--Haleon, a global leader in consumer health, today announced it has been honored in Fast Company's 2025 Brands That Matter list in the Family of Brands category, which highlights companies that created cultural moments for multiple brands across their portfolios. The annual list recognizes organizations that demonstrate cultural relevance, meaningful consumer connection, and a clear commitment to purpose. “We are incredibly proud to be recognized by Fast Company fo.
Business Wire • Dec 12, 2025

Haleon: Fairly Priced Given Limited Growth Drivers
Haleon (HLN) remains a solid consumer goods company, with strong brands like Sensodyne, but growth is incremental and largely price-driven. HLN's recent results show modest organic revenue growth, with volume gains limited and most categories outside oral health underperforming. The company's full-year organic revenue guidance is around 3.5%, but risks from subdued consumer demand and, over the longer term, limited innovation persist.
Seeking Alpha • Dec 8, 2025

First Eagle Overseas Equity ETF Q3 2025 Portfolio Update
Overseas Equity ETF posted a return of 7.27% in the third quarter of 2025. Leading contributors in the First Eagle Overseas Equity ETF this quarter included Samsung Electronics Co Ltd Pfd Non-Voting, Alibaba Group, Barrick Mining, Newmont and Prosus N.V. Class N. The leading detractors in the quarter were Shimano, FUCHS SE Pref Registered Shs, SMC Corporation, Haleon and Philip Morris.
Seeking Alpha • Nov 26, 2025

Haleon plc (HLN) Q3 2025 Sales Call Transcript
Haleon plc ( HLN ) Q3 2025 Sales Call October 30, 2025 5:00 AM EDT Company Participants Joanne Russell - Head of Investor Relations Dawn Allen - CFO & Director Conference Call Participants Guillaume Gerard Delmas - UBS Investment Bank, Research Division Olivier Nicolai David Hayes - Jefferies LLC, Research Division Jeremy Fialko - HSBC Global Investment Research Celine Pannuti - JPMorgan Chase & Co, Research Division Karel Zoete - Kepler Cheuvreux, Research Division Mikheil Omanadze - BNP Paribas Exane, Research Division Tom Sykes - Deutsche Bank AG, Research Division Warren Ackerman - Barclays Bank PLC, Research Division Edward Lewis - Rothschild & Co Redburn, Research Division Presentation Operator Good morning. Thank you for attending today's Haleon 2025 Quarter 3 Trading Statement.
Seeking Alpha • Oct 30, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Haleon plc American Depositary Shares (Each representing two) commission-free¹. Build wealth for the long term using automated trading and transfers.